Cigna Group
CI
295.44
+0.25
+0.08%
Cigna Group
US · CI
#312 by market cap
Listed 1970
295.44
+0.25
+0.08%
Live - 5344 symbols - heartbeat 12s ago
· 2026-11-03 20:02
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 26 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.3 percentage points.
Institutional ownership
- Held by institutions
- 92.58% -0.32pp
- Institutions
- 1,985 -26
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund79.00%
Hedge Fund3.63%
Public Company3.30%
Government Pension Fund2.35%
Private Company1.69%
Sovereign Wealth Fund1.50%
Insurance Company0.40%
Individual/Insider0.38%
Family Office/Trust0.24%
Other7.49%
Top holders as of 2026-06-30
BlackRock
8.87% · 23.44M sh
Vanguard Capital Management, LLC
7.10% · 18.76M sh
State Street Global Advisors
4.80% · 12.68M sh
Dodge & Cox
4.61% · 12.17M sh
MFS Investment Management
3.95% · 10.44M sh
Other
70.67%
Sanders Capital, LLC
3.84% · 10.14M sh
Geode Capital Management, LLC
2.37% · 6.27M sh
Vanguard Portfolio Management, LLC
2.36% · 6.23M sh
GQG Partners, LLC
2.24% · 5.91M sh
FMR
2.10% · 5.55M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 24 buys · 14 sells
| Name | Role | Stake |
|---|---|---|
| David Cordani | Executive Chairperson | 0.25% |
| Brian Evanko | Chief Executive Officer | 0.03% |
| Eric Foss | Lead Independent Director | 0.01% |
| Jason Sadler | President of International Health Cigna Healthcare | 0.01% |
| Eric Palmer | Former Executive Vice President of Enterprise Strategy | 0.01% |
| Nicole Jones | Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer | 0.01% |
| William DeLaney | Former Independent Director | 0.01% |
| David Brailer | Former Executive VP, Chief Health Officer & Chief Transformation Officer | 0.01% |
| Adam Kautzner | Pres. of Evernorth Care Mgmt & Express Scripts & EVP of Cust. Personalization | 0.01% |
| Matt Perlberg | Executive VP of Customer Innovation and President of Evernorth Pharmacy & Care Delivery | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-02 | F. Neville | Executive VP & Special Advisor to the CEO | Automatic Disposition | -617 | $284.05 |
| 2026-08-31 | Brian Evanko | Chief Executive Officer | Other Acquisition | +3,113 | -- |
| 2026-08-31 | Brian Evanko | Chief Executive Officer | Other Derivative Acquisition | +6,716 | $281.13 |
| 2026-08-30 | George Kurian | Independent Director | Other Derivative Acquisition | +108 | -- |
| 2026-08-17 | Nicole Jones | Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer | Automatic Disposition | -2,677 | $279.61 |
| 2026-08-05 | Bryan Holgerson | President of Cigna Healthcare U.S. & Executive VP of Customer Health Outcomes | Other Derivative Acquisition | +2 | -- |
| 2026-08-04 | Nicole Jones | Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer | Derivative Exercise and Retained | +1,301 | $192.02 |
| 2026-08-03 | Nicole Jones | Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer | Automatic Disposition | -5,391 | $276.27 |
| 2026-08-03 | Nicole Jones | Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer | Derivative Exercise and Sale | -14,045 | $192.02–276.27 |
| 2026-06-30 | Jason Sadler | President of International Health Cigna Healthcare | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Bryan Holgerson | President of Cigna Healthcare U.S. & Executive VP of Customer Health Outcomes | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Paul Sanford | Executive Vice President & Chief Strategy Acceleration Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Adam Kautzner | Pres. of Evernorth Care Mgmt & Express Scripts & EVP of Cust. Personalization | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Matt Perlberg | Executive VP of Customer Innovation and President of Evernorth Pharmacy & Care Delivery | Initial Statement of Beneficial | 0 | -- |
| 2026-06-11 | Jamie Kates | Senior VP & Tax and Global Chief Accounting Officer | Derivative Exercise and Sale | -899 | $152.89–298.61 |
| 2026-05-31 | Durga Koka | Executive Vice President & Global Chief Information Officer | Sale to Issuer | -729 | $275.53 |
| 2026-05-28 | George Kurian | Independent Director | Other Derivative Acquisition | +108 | -- |
| 2026-05-12 | David Cordani | Executive Chairperson | Derivative Exercise and Retained | +23,429 | $149.14–197.35 |
| 2026-05-11 | David Cordani | Executive Chairperson | Automatic Disposition | -12,764 | $298.24–298.53 |
| 2026-05-11 | David Cordani | Executive Chairperson | Derivative Exercise and Sale | -189,114 | $149.14–298.24 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-03 20:02:36 · For reference only, not investment advice and not tailored to your situation.
Cigna Group discussion 0 comments